Logo image of AXS.AS

ACCSYS TECHNOLOGIES PLC (AXS.AS) Stock Fundamental Analysis

AMS:AXS - Euronext Amsterdam - GB00BQQFX454 - Common Stock - Currency: EUR

0.713  +0.03 (+4.55%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AXS. AXS was compared to 11 industry peers in the Paper & Forest Products industry. The financial health of AXS is average, but there are quite some concerns on its profitability. AXS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AXS has reported negative net income.
In the past year AXS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AXS reported negative net income in multiple years.
AXS had a positive operating cash flow in each of the past 5 years.
AXS.AS Yearly Net Income VS EBIT VS OCF VS FCFAXS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.92%, AXS is doing worse than 72.73% of the companies in the same industry.
AXS has a Return On Equity of -35.12%. This is in the lower half of the industry: AXS underperforms 72.73% of its industry peers.
AXS has a worse Return On Invested Capital (2.34%) than 63.64% of its industry peers.
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROIC 2.34%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
AXS.AS Yearly ROA, ROE, ROICAXS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Operating Margin of AXS (3.50%) is comparable to the rest of the industry.
AXS has a Gross Margin of 31.12%. This is in the lower half of the industry: AXS underperforms 63.64% of its industry peers.
AXS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 31.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
AXS.AS Yearly Profit, Operating, Gross MarginsAXS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXS is destroying value.
Compared to 1 year ago, AXS has more shares outstanding
The number of shares outstanding for AXS has been increased compared to 5 years ago.
Compared to 1 year ago, AXS has an improved debt to assets ratio.
AXS.AS Yearly Shares OutstandingAXS.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXS.AS Yearly Total Debt VS Total AssetsAXS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

AXS has an Altman-Z score of 0.72. This is a bad value and indicates that AXS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.72, AXS is doing worse than 72.73% of the companies in the same industry.
AXS has a debt to FCF ratio of 4.92. This is a neutral value as AXS would need 4.92 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.92, AXS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
AXS has a Debt/Equity ratio of 0.70. This is a neutral value indicating AXS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.70, AXS is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Altman-Z 0.72
ROIC/WACC0.31
WACC7.48%
AXS.AS Yearly LT Debt VS Equity VS FCFAXS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

AXS has a Current Ratio of 2.03. This indicates that AXS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.03, AXS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that AXS should not have too much problems paying its short term obligations.
AXS has a Quick ratio of 1.34. This is amongst the best in the industry. AXS outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.34
AXS.AS Yearly Current Assets VS Current LiabilitesAXS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The earnings per share for AXS have decreased strongly by -12.05% in the last year.
AXS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.31%.
AXS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.62% yearly.
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%

3.2 Future

Based on estimates for the next years, AXS will show a very strong growth in Earnings Per Share. The EPS will grow by 43.49% on average per year.
The Revenue is expected to grow by 4.61% on average over the next years.
EPS Next Y-212.93%
EPS Next 2Y48.71%
EPS Next 3Y43.49%
EPS Next 5YN/A
Revenue Next Year-1.89%
Revenue Next 2Y3.64%
Revenue Next 3Y7.26%
Revenue Next 5Y4.61%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AXS.AS Yearly Revenue VS EstimatesAXS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
AXS.AS Yearly EPS VS EstimatesAXS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1

2

4. Valuation

4.1 Price/Earnings Ratio

AXS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 89.32, the valuation of AXS can be described as expensive.
AXS's Price/Forward Earnings is on the same level as the industry average.
AXS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 89.32
AXS.AS Price Earnings VS Forward Price EarningsAXS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXS is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.75
EV/EBITDA 14.85
AXS.AS Per share dataAXS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as AXS's earnings are expected to grow with 43.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.71%
EPS Next 3Y43.49%

0

5. Dividend

5.1 Amount

AXS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACCSYS TECHNOLOGIES PLC

AMS:AXS (5/30/2025, 7:00:00 PM)

0.713

+0.03 (+4.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)11-24 2025-11-24
Inst Owners39.62%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner ChangeN/A
Market Cap171.41M
Analysts85.45
Price Target0.98 (37.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 89.32
P/S 1.25
P/FCF 12.75
P/OCF 11.22
P/B 1.89
P/tB 2.04
EV/EBITDA 14.85
EPS(TTM)-0.13
EYN/A
EPS(NY)0.01
Fwd EY1.12%
FCF(TTM)0.06
FCFY7.84%
OCF(TTM)0.06
OCFY8.92%
SpS0.57
BVpS0.38
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROCE 3.12%
ROIC 2.34%
ROICexc 2.82%
ROICexgc 2.97%
OM 3.5%
PM (TTM) N/A
GM 31.12%
FCFM 9.8%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Debt/EBITDA 4.43
Cap/Depr 19.53%
Cap/Sales 1.34%
Interest Coverage 2.15
Cash Conversion 107.28%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.34
Altman-Z 0.72
F-Score3
WACC7.48%
ROIC/WACC0.31
Cap/Depr(3y)378.65%
Cap/Depr(5y)352.01%
Cap/Sales(3y)19.57%
Cap/Sales(5y)19.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
EPS Next Y-212.93%
EPS Next 2Y48.71%
EPS Next 3Y43.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%
Revenue Next Year-1.89%
Revenue Next 2Y3.64%
Revenue Next 3Y7.26%
Revenue Next 5Y4.61%
EBIT growth 1Y-59.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year235.32%
EBIT Next 3Y67.72%
EBIT Next 5YN/A
FCF growth 1Y126.36%
FCF growth 3Y-22.01%
FCF growth 5YN/A
OCF growth 1Y3050.58%
OCF growth 3Y-29.11%
OCF growth 5Y88.8%